Calcium Channel Blockers and Chemotherapy in Lymphoma
Author Information
Author(s): J Shamash, AH Salam, DC Davies, A Williams, S Joel, TA Lister
Primary Institution: ICRF Department of Medical Oncology, St Bartholomew's Hospital
Hypothesis
Can calcium channel blockers enhance the effectiveness of chemotherapy in treating low-grade non-Hodgkin's lymphoma?
Conclusion
Dantrolene and azumolene showed significant cytotoxic effects on lymphoma cells, while nimodipine did not.
Supporting Evidence
- Dantrolene and azumolene reduced viable cell counts by 70-90%.
- Nimodipine showed no significant effect on cell viability.
- The study suggests further evaluation of dantrolene and azumolene for lymphoma treatment.
Takeaway
Some medicines that block calcium can help kill cancer cells in lymphoma, but one of them didn't work at all.
Methodology
The study used in vitro cell cultures of lymphoma cells to assess the effects of dantrolene, azumolene, and nimodipine on cell viability.
Limitations
The study was conducted in vitro, which may not fully represent in vivo conditions.
Participant Demographics
Seven low-grade B-cell lymphomas were studied, including various subtypes.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website